Redefining Postpartum Depression Treatment: The Clinical Potential of Zuranolone

被引：2
|
作者：
Nashwan, Abdulqadir J. [1 ,2 ]
Rehan, Syeda Tayyaba [3 ]
Imran, Laiba [3 ]
Abbas, Samina Ghulam [3 ]
Khan, Sara [4 ]
机构：
[1] Qatar Univ, Coll Hlth Sci, Dept Publ Hlth, QU Hlth, Doha, Qatar
[2] Hamad Med Corp, Doha, Qatar
[3] Dow Univ Hlth Sci, Karachi 74200, Pakistan
[4] Bahria Univ, Inst Profess Psychol, Karachi 75260, Pakistan
来源：
ASIAN JOURNAL OF PSYCHIATRY | 2024年 / 91卷
关键词：
D O I：
10.1016/j.ajp.2023.103849
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Zuranolone for the Treatment of Postpartum Depression
    St. Onge, Erin
    Patel, Priti
    Whitner, Chardae
    [J]. JOURNAL OF PHARMACY TECHNOLOGY, 2024,
  • [2] Zuranolone for the Treatment of Postpartum Depression
    Deligiannidis, Kristina M.
    Meltzer-Brody, Samantha
    Maximos, Bassem
    Peeper, E. Quinn
    Freeman, Marlene
    Lasser, Robert
    Bullock, Amy
    Kotecha, Mona
    Li, Sigui
    Forrestal, Fiona
    Rana, Nilanjana
    Garcia, Manny
    Leclair, Bridgette
    Doherty, James
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2023, 180 (09): : 668 - 675
  • [3] Zuranolone: A Breakthrough in the Treatment of Postpartum Depression
    Diaz, Zobeida M.
    Adashi, Eli Y.
    [J]. JOURNAL OF WOMENS HEALTH, 2024, 33 (04) : 407 - 408
  • [4] Zuranolone: A Narrative Review of a New Oral Treatment for Postpartum Depression
    Hitt, Emily M.
    [J]. CLINICAL THERAPEUTICS, 2024, 46 (05) : 433 - 438
  • [5] Effect of Zuranolone vs Placebo in Postpartum Depression A Randomized Clinical Trial
    Deligiannidis, Kristina M.
    Meltzer-Brody, Samantha
    Gunduz-Bruce, Handan
    Doherty, James
    Jonas, Jeffrey
    Li, Sigui
    Sankoh, Abdul J.
    Silber, Christopher
    Campbell, Andrew D.
    Werneburg, Brian
    Kanes, Stephen J.
    Lasser, Robert
    [J]. JAMA PSYCHIATRY, 2021, 78 (09) : 951 - 959
  • [6] Zuranolone (Zurzuvae) - An Oral Drug for Postpartum Depression
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1692): : 201 - 203
  • [7] Exploring the clinical potentials of zuranolone in managing postpartum depression: A new therapeutic horizon
    Nashwan, Abdulqadir J.
    Rehan, Syeda Tayyaba
    Imran, Laiba
    Abbas, Samina Ghulam
    Khan, Sara Fahim
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2024, 132
  • [8] Zuranolone, a neuroactive drug, used in the treatment of postpartum depression by modulation of GABAA receptors
    Sharma, Renu
    Bansal, Pranjal
    Saini, Lokesh
    Sharma, Nidhi
    Dhingra, Richa
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2024, 238
  • [9] Zuranolone: The First FDA-Approved Oral Treatment Option for Postpartum Depression
    Barnes, Kylie N.
    Vogl, Claire M.
    Nelson, Leigh Anne
    [J]. ANNALS OF PHARMACOTHERAPY, 2023,
  • [10] Zuranolone in postpartum depression: a profile of its use in the USA
    Blair, Hannah A.
    [J]. DRUGS & THERAPY PERSPECTIVES, 2024, 40 (06) : 195 - 202
12345